Resting heart rate and the risk of developing impaired fasting glucose and diabetes: The Kailuan prospective study

International Journal of Epidemiology

Volumn 44, Issue 2, 2015, Pages 689-699

  Wang, Liang ^a   Cui, Liufu ^b   Wang, Yanxue ^b   Vaidya, Anand ^c   Chen, Shuohua ^b   Zhang, Caifeng ^b   Zhu, Ying ^b   Li, Dongqing ^b   Hu, Frank B ^d   Wu, Shouling ^b   Gao, Xiang ^d,e  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b HEBEI UNITED UNIVERSITY   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Heart rate; Prospective study

Indexed keywords

BLOOD; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETES; DISEASE INCIDENCE; FASTING; GLUCOSE; HEALTH RISK; META-ANALYSIS;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTING HEART RATE; RISK ASSESSMENT; ARRHYTHMIAS, CARDIAC; BLOOD; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GLUCOSE INTOLERANCE; HEART RATE; INCIDENCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDIABETIC STATE; RISK FACTOR;

GLUCOSE BLOOD LEVEL;

ARRHYTHMIAS, CARDIAC; BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FASTING; FEMALE; GLUCOSE INTOLERANCE; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDIABETIC STATE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84936752753     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv079     Document Type: Article

References (39)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care 2004;27:1047-53.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services (CDC), 2011.
3. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101.
4. Xu Y, Wang L, He J et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:94859.
5. Gu D, Gupta A, Muntner P et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation 2005; 112:658-65.
6. Grassi G, Vailati S, Bertinieri G et al. Heart rate as marker of sympathetic activity. J Hypertens 1998;16:1635-39.
7. Grantham NM, Magliano DJ, Tanamas SK, Söderberg S, Schlaich MP, Shaw JE. Higher heart rate increases risk of diabetes among men: The Australian diabetes obesity and lifestyle study. Diabet Med 2013;30:421-27.
8. Shigetoh Y, Adachi H, Yamagishi S et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009;22:151-55.
9. Carnethon MR, Yan L, Greenland P et al. Resting heart rate in middle age and diabetes development in older age. Diabetes Care 2008;31:335-39.
10. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation 2003;107: 2190-95.
11. Carnethon MR, Prineas RJ, Temprosa M et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care 2006; 29:914-19.
12. Nagaya T, Yoshida H, Takahashi H, Kawai M. Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type 2 diabetes mellitus. Int J Epidemiol 2010;39:215-22.
13. Bemelmans RH, Wassink AM, van der Graaf Yet al. Risk of elevated resting heart rate on the development of type 2 diabetes in patients with clinically manifest vascular diseases. Eur J Endocrinol 2012;166:717-25.
14. Zhang X, Shu XO, Xiang YB et al. Resting heart rate and risk of type 2 diabetes in women. Int J Epidemiol 2010;39:900-06.
15. DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 108(Suppl 3): 3B-24B.
16. O'Hartaigh B, Jiang CQ, Bosch JA et al. Independent and combined associations of abdominal obesity and seated resting heart rate with type 2 diabetes among older Chinese: the Guangzhou Biobank Cohort Study. Diabetes Metab Res Rev 2011;27: 298-306.
17. Stein PK, Barzilay JI, Domitrovich PP et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose and the metabolic syndrome: the Cardiovascular Health Study. Diabet Med 2007;24:855-63.
18. Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B. Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 2002;51: 803-07.
19. Wu S, Huang Z, Yang X et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 2012;5:48793.
20. Zhang Q, Zhou Y, Gao X et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke 2013;44:2451-56.
21. American Diabetic Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes 2003;Suppl 1:S5-20.
22. Hu FB, Manson JE, Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345:790-97.
23. Hoshide S, Kario K, Ishikawa J, Eguchi K, Shimada K. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure. Hypertens Res 2005;28:1003-08.
24. Kuramoto K, Ichikawa S, Hirai A, Kanada S, Nakachi T, Ogihara T. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res 2003;26:201-08.
25. Higgins JP, Thompson SC. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
26. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
28. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-69.
29. van Dan RM. The epidemiology of lifestyle and risk factor for type 2 diabetes. Eur J Epidemiol 2003;18:1115-25.
30. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993;21:618-23.
31. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997; 10:77-83.
32. Palatini P, Mos L, Santonastaso M et al. Resting heart rate as a predictor of body weight gain in the early stage of hypertension. Obesity (Silver Spring) 2011;19:618-23.
33. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens 1994;12:495-502.
34. Julius S, Gudbrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press 1992;1:9-19.
35. Flanagan DE, Vaile JC, Petley GW et al. The autonomic control of heart rate and insulin resistance in young adults. J Clin Endocrinol Metab 1999;84:1263-67.
36. Mancia G, Bousquet P, Elghozi JL et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007;25:909-20.
37. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70.
38. Shibao C, Gamboa A, Diedrich A et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 2007; 49:27-33.
39. Palatini P. Role of elevated heart rate in the development of cardiovascular disease in hypertension. Hypertension. 2011; 58: 745-50.